Circulating resistance to first-line HIV drug regimens.

Autor: Iwuji CC; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Boston, MA, USA. Electronic address: c.iwuji@bsms.ac.uk., Siedner MJ; Harvard Medical School, Boston, MA, USA.
Jazyk: angličtina
Zdroj: The lancet. HIV [Lancet HIV] 2020 Feb; Vol. 7 (2), pp. e77-e78. Date of Electronic Publication: 2019 Dec 07.
DOI: 10.1016/S2352-3018(19)30374-1
Databáze: MEDLINE